Monte Rosa Therapeutics Inc (GLUE)

CapEx to Revenue

27.88%

TTM · Retrieved:

GLUE logo

GLUE CapEx to Revenue

Current (TTM)27.88%
GLUE TTM CapEx/Revenue (27.88% → 27.88%)
More history is needed to export this chart.

GLUE capex to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Monte Rosa Therapeutics Inc CapEx to Revenue — Published TTM snapshot
RetrievedCapEx to Revenue
27.8797%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.